Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension | Zendy

V.A. Badar | Zendy; SachinK Hiware | Zendy; M P Shrivastava | Zendy; VR Thawani | Zendy; MM Hardas | Zendy

Open Access

Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension

Author(s) -

V.A. Badar,

SachinK Hiware,

M P Shrivastava,

VR Thawani,

MM Hardas

Publication year - 2011

Publication title -

indian journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.286

H-Index - 59

eISSN - 1998-3751

pISSN - 0253-7613

DOI - 10.4103/0253-7613.83117

Subject(s) - nebivolol , atenolol , essential hypertension , medicine , blood pressure , lipid profile , pharmacology , metabolic syndrome , blood sugar , vasodilation , adverse effect , cardiology , endocrinology , obesity , cholesterol , diabetes mellitus

Nebivolol is a third-generation β-blocker, with highest β(1) selectivity and nitric-oxide-derived vasodilatation. It also exhibits antiproliferative and antioxidant property that has beneficial metabolic profile compared to second-generation β blockers like atenolol. This study was planned to study the comparative effects of nebivolol and atenolol on metabolic parameters in patients with essential hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research